RxDoctor Payments Data

Patrick Szaraz

Family · Miami, FLNPI 1215301890

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $287,915 of the $326,889 with a category attached, or 88.1%. AbbVie accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. 2025 is the largest year on record at $291,115, more than ten times the $791 reported in 2022. Among family clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$326,889in general payments, 2019–2025

Across 466 payments — averaging $701.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$327K
  • Galderma Laboratories, L.p.$16

What the payments were for

  • Speaking & faculty fees$287,91588%
  • Travel & lodging$31,94910%
  • Food & beverage$7,0252%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)465$326,872
Galderma Laboratories, L.p.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$326,889 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Other family in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →